| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $31K | -55.8% |
| R&D Expense | $897K | +18.4% |
| SG&A Expense | $2.9M | -27.9% |
| Operating Income | -$4.5M | +25.9% |
| Net Income | -$4.6M | +25.2% |
| EPS (Basic) | -$0.17 | +22.7% |
| EPS (Diluted) | -$0.17 | +22.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $5K | -27.9% |
| Current Assets | $315K | -72.5% |
| Total Assets | $315K | -72.5% |
| Current Liabilities | $3.0M | +192.4% |
| Total Liabilities | $3.0M | +192.4% |
| Stockholders' Equity | -$2.7M | -2379.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.6M | -9.8% |
| Financing Cash Flow | $1.7M | -45.4% |